• Welcome to Genegraft website


    GENEGRAFT has ended on 31st December 2017, the website will stay alive for another year. 
    Results of the excellent work carried out in Genegraft can be found in the
    Final Publishable Summary



    GENEGRAFT is a ‘bench to bedside’ project aims to find a durable and efficient treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) one of the most severe orphan diseases of the skin.

    The GENEGRAFT project is a collaborative project funded by the European Union as part of the 7th framework programme. GENEGRAFT - contract N° HEALTH-F2-2011-261392 - started on March 1st 2011.

  • News

    • Read Genegraft last publishable summary (April 2017): click here


  •  RE(ACT) Congress: International congress on research of Rare and Orphan diseases March 9-12, 2016 Read more...

    • ECRD 2016 : The European Conference on Rare Diseases & Orphan Products May 26-28, 2016, Edingburgh Read more...

    Read more event